An eye for discovery.
Vision research has often led to significant advances in our understanding of biology. There has also been particular success in translating basic research in the eye into breakthrough clinical therapies that mark important milestones for ophthalmology and also for medical research. Anti-VEGF therapy for age-related macular degeneration was named as one of the top ten science advancements of the year 2006. Only two years later, successful transfer of the RPE65 gene into retinal pigment epithelium of patients with Leber congenital amaurosis was noted as one of the most important clinical applications of gene therapy. The articles in this Review series outline current developments in vision research and highlight its continued importance in ophthalmology and medicine.
Stahl
Andreas
A
Department of Ophthalmology, Children’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Smith
Lois E H
LE
D000375:Aging; D005128:Eye Diseases / Q000628:therapy*; D015316:Genetic Therapy; D006801:Humans; D009885:Ophthalmology / Q000639:trends*; D057905:Stem Cell Research; D033581:Stem Cell Transplantation; D014793:Visual Cortex / Q000502:physiology; D014796:Visual Perception
N Engl J Med. 2006 Oct 5;355(14):1419-31
17021318
J Clin Invest. 2010 Sep;120(9):3073-83
20811163
Science. 2006 Dec 22;314(5807):1850-5
17185566
J Clin Invest. 2010 Sep;120(9):3054-63
20811161
J Clin Invest. 2006 Dec;116(12):3266-76
17111048
Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10457-61
7479819
Proc Natl Acad Sci U S A. 1996 May 14;93(10):4851-6
8643492
J Clin Invest. 2010 Sep;120(9):3012-21
20811157
Clin Biochem. 2006 Mar;39(3):249-58
16332362
J Clin Invest. 2003 Apr;111(8):1171-80
12697736
J Clin Invest. 2004 Sep;114(6):765-74
15372100
Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2542-6
16723468
Br J Exp Pathol. 1948 Feb;29(1):58-69
18865105
Lancet. 1980 Apr 26;1(8174):896-8
6103257
J Clin Invest. 2010 Sep;120(9):3064-72
20811162
Invest Ophthalmol Vis Sci. 1990 Jul;31(7):1231-7
1973155
Arch Ophthalmol. 1967 Mar;77(3):405-9
4960032
Br J Ophthalmol. 1996 Jan;80(1):9-14
8664242
Arch Ophthalmol. 2007 Jan;125(1):30-7
17210849
N Engl J Med. 2006 Oct 5;355(14):1474-85
17021323
J Clin Invest. 2010 Sep;120(9):3042-53
20811160
Arch Ophthalmol. 1996 Jan;114(1):66-71
8540853
J Clin Invest. 2010 Sep;120(9):3033-41
20811159
Arch Ophthalmol. 2004 Apr;122(4):598-614
15078679
Arch Ophthalmol. 2004 Apr;122(4):477-85
15078664
Nature. 2005 Jun 23;435(7045):1102-7
15973409
N Engl J Med. 2008 May 22;358(21):2240-8
18441370
N Engl J Med. 2006 Oct 5;355(14):1432-44
17021319
Arch Ophthalmol. 2007 Jan;125(1):74-9
17210855
Ophthalmol Clin North Am. 2003 Dec;16(4):639-45
14741004
Acta Physiol Scand. 1966 Jun;67(2):201-7
5963406
Bull World Health Organ. 2004 Nov;82(11):844-51
15640920
J Clin Invest. 2010 Sep;120(9):3022-32
20811158
N Engl J Med. 2008 May 22;358(21):2231-9
18441371
Science. 2002 Feb 8;295(5557):1077-9
11834836
Nat Med. 2008 Oct;14(10):1067-76
18836459